Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$690837.0.

  • Cumberland Pharmaceuticals' Cash from Investing Activities fell 46428.67% to -$690837.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 58074.6%. This contributed to the annual value of $57842.0 for FY2024, which is 15472.54% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Cash from Investing Activities stood at -$690837.0, which was down 46428.67% from $285864.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Cash from Investing Activities registered a high of $680805.0 during Q3 2022, and its lowest value of -$13.5 million during Q1 2022.
  • For the 5-year period, Cumberland Pharmaceuticals' Cash from Investing Activities averaged around -$834597.9, with its median value being -$95073.0 (2023).
  • Examining YoY changes over the last 5 years, Cumberland Pharmaceuticals' Cash from Investing Activities showed a top increase of 72895.4% in 2022 and a maximum decrease of 415389.69% in 2022.
  • Over the past 5 years, Cumberland Pharmaceuticals' Cash from Investing Activities (Quarter) stood at -$26795.0 in 2021, then plummeted by 2291.39% to -$640772.0 in 2022, then skyrocketed by 140.68% to $260639.0 in 2023, then tumbled by 110.29% to -$26809.0 in 2024, then plummeted by 2476.88% to -$690837.0 in 2025.
  • Its Cash from Investing Activities was -$690837.0 in Q3 2025, compared to $285864.0 in Q2 2025 and -$1.2 million in Q1 2025.